Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Mining the Human Gut Microbiota for Immunomodulatory Organisms.

Geva-Zatorsky N, Sefik E, Kua L, Pasman L, Tan TG, Ortiz-Lopez A, Yanortsang TB, Yang L, Jupp R, Mathis D, Benoist C, Kasper DL.

Cell. 2017 Feb 23;168(5):928-943.e11. doi: 10.1016/j.cell.2017.01.022. Epub 2017 Feb 16.

2.

Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice.

Tan TG, Sefik E, Geva-Zatorsky N, Kua L, Naskar D, Teng F, Pasman L, Ortiz-Lopez A, Jupp R, Wu HJ, Kasper DL, Benoist C, Mathis D.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8141-E8150. Epub 2016 Nov 23.

3.

MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.

Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM, Burzyn D, Ortiz-Lopez A, Lobera M, Yang J, Ghosh S, Earl A, Snapper SB, Jupp R, Kasper D, Mathis D, Benoist C.

Science. 2015 Aug 28;349(6251):993-7. doi: 10.1126/science.aaa9420. Epub 2015 Aug 13.

4.

In-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulation.

Mazuc E, Guglielmi L, Bec N, Parez V, Hahn CS, Mollevi C, Parrinello H, Desvignes JP, Larroque C, Jupp R, Dariavach P, Martineau P.

PLoS One. 2014 Aug 14;9(8):e104998. doi: 10.1371/journal.pone.0104998. eCollection 2014.

5.

The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery.

Soars MG, Barton P, Ismair M, Jupp R, Riley RJ.

Drug Metab Dispos. 2012 Aug;40(8):1641-8. doi: 10.1124/dmd.111.042382. Epub 2012 May 15.

PMID:
22587986
6.

Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child.

Williams B, Neth O, Shingadia D, Dixon G, Jupp RS, Rosendahl K, Eastwood D, Klein N, Brogan P.

Pediatr Infect Dis J. 2010 Jan;29(1):88-9. doi: 10.1097/INF.0b013e3181b78e8b.

PMID:
19884872
7.

Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation.

Williams AS, Eynott PR, Leung SY, Nath P, Jupp R, De Sanctis GT, Resnick R, Adcock IM, Chung KF.

Pulm Pharmacol Ther. 2009 Feb;22(1):27-32. doi: 10.1016/j.pupt.2008.11.002. Epub 2008 Nov 14.

PMID:
19041950
8.

A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils.

Royer JF, Schratl P, Carrillo JJ, Jupp R, Barker J, Weyman-Jones C, Beri R, Sargent C, Schmidt JA, Lang-Loidolt D, Heinemann A.

Eur J Clin Invest. 2008 Sep;38(9):663-71. doi: 10.1111/j.1365-2362.2008.01989.x.

PMID:
18837743
9.

Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation.

Das J, Eynott P, Jupp R, Bothwell A, Van Kaer L, Shi Y, Das G.

Nat Med. 2006 Dec;12(12):1345-6; author reply 1347. No abstract available.

PMID:
17151684
10.

Rapid simultaneous cloning of drug targets from multiple mammalian species.

Jupp R, Dusanjh PK, Walding A, McHale M, Belfield GP, Delaney SJ.

Altern Lab Anim. 2006 Jun;34(3):295-303.

PMID:
16831061
11.

Functional genomics.

Jupp RA, Palmer AM, Greengrass PM; Society for Medicines Research.

Drug News Perspect. 2000 Apr;13(3):188-92.

PMID:
12937609
12.

Molecular characterization of antigen-induced lung inflammation in a murine model of asthma.

Daheshia M, Tian N, Connolly T, Drawid A, Wu Q, Bienvenu JG, Cavallo J, Jupp R, De Sanctis GT, Minnich A.

Ann N Y Acad Sci. 2002 Dec;975:148-59.

PMID:
12538161
13.

Assessing dietary fat intake in chronic disease rehabilitation programs.

Watson S, Webster WA 4th, Feigenbaum MS, Jupp R, Senn M, Wracker C, Blackhurst D, Hendricks M, Durstine JL.

J Cardiopulm Rehabil. 2002 May-Jun;22(3):161-7.

PMID:
12042683
14.

Making sense of microarray data distributions.

Hoyle DC, Rattray M, Jupp R, Brass A.

Bioinformatics. 2002 Apr;18(4):576-84.

PMID:
12016055
15.

Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes.

Temple R, Allen E, Fordham J, Phipps S, Schneider HC, Lindauer K, Hayes I, Lockey J, Pollock K, Jupp R.

Am J Respir Cell Mol Biol. 2001 Oct;25(4):425-33.

PMID:
11694447
16.

Analysis of cellular adhesion by microarray expression profiling.

Brenner V, Lindauer K, Parkar A, Fordham J, Hayes I, Stow M, Gama R, Pollock K, Jupp R.

J Immunol Methods. 2001 Apr;250(1-2):15-28.

PMID:
11251219
17.

Large-scale expression, refolding, and purification of the catalytic domain of human macrophage metalloelastase (MMP-12) in Escherichia coli.

Parkar AA, Stow MD, Smith K, Panicker AK, Guilloteau JP, Jupp R, Crowe SJ.

Protein Expr Purif. 2000 Nov;20(2):152-61.

PMID:
11049739
18.

A case of factitious hypocalcaemia.

Johnston JD, Jupp RA.

Ann Clin Biochem. 1998 May;35 ( Pt 3):442-3. No abstract available.

PMID:
9635116
19.

In vitro activity of hepatitis B virus polymerase: requirement for distinct metal ions and the viral epsilon stem-loop.

Urban M, McMillan DJ, Canning G, Newell A, Brown E, Mills JS, Jupp R.

J Gen Virol. 1998 May;79 ( Pt 5):1121-31.

PMID:
9603327
20.

Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements.

Simmen KA, Newell A, Robinson M, Mills JS, Canning G, Handa R, Parkes K, Borkakoti N, Jupp R.

J Virol. 1997 May;71(5):3886-94.

21.

Near-patient testing by proxy.

Johnston JD, Jupp RA, Mitchell WD.

Ann Clin Biochem. 1997 Jan;34 ( Pt 1):104-5. No abstract available.

PMID:
9022896
22.

Cloning, expression and characterization of the proteinase from human herpesvirus 6.

Tigue NJ, Matharu PJ, Roberts NA, Mills JS, Kay J, Jupp R.

J Virol. 1996 Jun;70(6):4136-41.

23.

The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.

Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA.

J Virol. 1996 May;70(5):3207-14.

24.
26.
27.
28.
29.

The DNA-binding subunit of human transcription factor IID can interact with the TATA box as a multimer.

Jupp R, Flores O, Nelson JA, Ghazal P.

J Biol Chem. 1993 Aug 5;268(22):16105-8.

30.
31.

Creatine phosphate (Neoton) as an additive to St. Thomas' Hospital cardioplegic solution (Plegisol). Results of a clinical study.

Chambers DJ, Braimbridge MV, Kosker S, Yamada M, Jupp RA, Crowther A.

Eur J Cardiothorac Surg. 1991;5(2):74-81.

PMID:
2018658
32.

Haemostatic changes in uncomplicated bone marrow transplants.

Collins P, Jones B, Uthayakumar S, Pocock C, Jupp R, Gutteridge G, Chopra R, Blare S, Newland A.

Bone Marrow Transplant. 1991;7 Suppl 2:54. No abstract available.

PMID:
1878719
33.

Substrate cleavage by HIV-1 proteinase.

Jupp RA, Richards AD, Phylip LH, Kay J, Konvalinka J, Strop P, Kostka V, Scarborough PE, Farmerie WG, Dunn BM.

Adv Exp Med Biol. 1991;306:461-7. No abstract available.

PMID:
1812743
34.

In vitro inhibition of HIV-1 proteinase by cerulenin.

Moelling K, Schulze T, Knoop MT, Kay J, Jupp R, Nicolaou G, Pearl LH.

FEBS Lett. 1990 Feb 26;261(2):373-7.

35.

The selectivity of statine-based inhibitors against various human aspartic proteinases.

Jupp RA, Dunn BM, Jacobs JW, Vlasuk G, Arcuri KE, Veber DF, Perlow DS, Payne LS, Boger J, de Laszlo S, et al.

Biochem J. 1990 Feb 1;265(3):871-8.

36.

Comparison of standard (non-oxygenated) vs. oxygenated St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol).

Chambers DJ, Kosker S, Takahashi A, Sakai A, Baharakakis S, Manzanera G, Jupp RA, Smith LD, Braimbridge MV.

Eur J Cardiothorac Surg. 1990;4(10):549-55.

PMID:
2245049
37.

X-ray studies of aspartic proteinase-statine inhibitor complexes.

Cooper JB, Foundling SI, Blundell TL, Boger J, Jupp RA, Kay J.

Biochemistry. 1989 Oct 17;28(21):8596-603.

PMID:
2690945
38.

CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.

Wood JM, Criscione L, de Gasparo M, Bühlmayer P, Rüeger H, Stanton JL, Jupp RA, Kay J.

J Cardiovasc Pharmacol. 1989 Aug;14(2):221-6.

PMID:
2476594
39.

Stabilisation of cathepsin E by ATP.

Thomas DJ, Richards AD, Jupp RA, Ueno E, Yamamoto K, Samloff IM, Dunn BM, Kay J.

FEBS Lett. 1989 Jan 30;243(2):145-8.

40.

Clinical validation of St. Thomas' Hospital cardioplegic solution No. 2 (Plegisol).

Chambers DJ, Sakai A, Braimbridge MV, Kosker S, Manzanera G, Kind PR, Jupp RA, Smith LD, Slavin B.

Eur J Cardiothorac Surg. 1989;3(4):346-52.

PMID:
2624805
41.
42.

Magnesium and coronary revascularization.

Harris MN, Crowther A, Jupp RA, Aps C.

Br J Anaesth. 1988 Jun;60(7):779-83.

43.

Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130.

Bonelli G, Kay J, Tessitore L, Jupp RA, Isidoro C, Norey CG, Autelli R, Richards AD, Baccino FM.

Biol Chem Hoppe Seyler. 1988 May;369 Suppl:323-7.

PMID:
3202970
44.

Aspartic proteinases and inhibitors for their control in health and disease.

Kay J, Jupp RA, Norey CG, Richards AD, Reid WA, Taggart RT, Samloff IM, Dunn BM.

Adv Exp Med Biol. 1988;240:1-11. No abstract available.

PMID:
3072839
45.

Adaptation of coenzyme stimulation assays for the nutritional assessment of vitamins B1, B2 and B6 using the Cobas Bio centrifugal analyser.

Mount JN, Heduan E, Herd C, Jupp R, Kearney E, Marsh A.

Ann Clin Biochem. 1987 Jan;24 ( Pt 1):41-6.

PMID:
3827183
46.

Chronic splenomegaly in Nairobi, Kenya. I. Epidemiology, malarial antibody and immunoglobulin levels.

De Cock KM, Hodgen AN, Lucas SB, Jupp RA, Slavin B, Arap Siongok TK, Rees PH.

Trans R Soc Trop Med Hyg. 1987;81(1):100-6.

PMID:
3445295
47.

Chronic splenomegaly in Nairobi, Kenya. II. Portal hypertension.

De Cock KM, Awadh S, Raja RS, Wankya BM, Jupp RA, Slavin B, Arap Siongok TK, Rees PH, Bertrand J, Lucas SB.

Trans R Soc Trop Med Hyg. 1987;81(1):107-10.

PMID:
3127951
48.

Immunoglobin M and malarial antibody levels in hyper-reactive malarial splenomegaly.

De Cock KM, Hodgen AN, Jupp RA, Slavin B, Siongok TK, Rees PH, Lucas SB.

J Trop Med Hyg. 1986 Jun;89(3):119-21.

PMID:
3773024
49.

Comparison of immunoglobulin and malaria antibody values in rural Kenyans.

De Cock KM, Rees PH, Hodgen AN, Jupp RA, Slavin B, Siongok TK.

Br Med J (Clin Res Ed). 1984 Nov 24;289(6456):1422-3. No abstract available.

50.

Obscure splenomegaly in the tropics that is not the tropical splenomegaly syndrome.

DeCock KM, Lucas SB, Rees PH, Hodgen AN, Jupp RA, Slavin B.

Br Med J (Clin Res Ed). 1983 Nov 5;287(6402):1347-8. No abstract available.

Supplemental Content

Support Center